查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1790430

美国DNA 合成市场规模、份额和趋势分析报告：按服务类型、应用、最终用途和细分市场预测，2025 年至 2033 年

U.S. DNA Synthesis Market Size, Share & Trends Analysis Report By Service Type (Gene Synthesis, Oligonucleotide Synthesis), By Application (Research Development, Diagnostics), By End Use, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10个工作天内

价格

美国DNA合成市场摘要

美国DNA合成市场规模预计在2024年达到12.5亿美元，预计到2033年将达到46.2亿美元，2025年至2033年的复合年增长率为15.93%。这一强劲成长主要源自于合成生物学、个人化医疗和生物技术研究领域日益增长的需求。美国基因编辑技术的进步和DNA合成成本的下降进一步加速了市场扩张。由于强大的研发投入和完善的生物技术基础设施，美国仍是全球基因组学创新的关键参与者。

目录

第一章调查方法与范围

第二章执行摘要

第 3 章美国DNA 合成市场变数、趋势与范围

  • 市场体系展望
    • 母市场展望
    • 相关/辅助市场前景。
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 美国DNA合成市场分析工具
    • 产业分析-波特五力分析
    • PESTEL分析

第四章美国DNA 合成市场：按服务类型进行的估计和趋势分析

  • 细分仪表板
  • 美国DNA合成市场服务类型波动分析
  • 美国DNA 合成市场规模及趋势分析（依服务类型），2021 年至 2033 年
  • 寡核苷酸合成
    • 按类型
    • 按长度
  • 基因合成
    • 按类型
    • 按长度

第五章：美国DNA 合成市场：依应用进行的估算与趋势分析

  • 细分仪表板
  • 美国DNA合成市场应用波动分析
  • 美国DNA 合成市场规模与应用趋势分析（2021-2033 年）
  • 研究与开发
    • 寡核苷酸合成
    • 基因合成
  • 诊断
  • 治疗药物
    • RNAi疗法
    • 反义和寡核苷酸治疗方法
    • 其他的

第六章：美国DNA 合成市场：依最终用途的估算与趋势分析

  • 细分仪表板
  • 美国DNA 合成市场波动分析（依最终用途）
  • 美国DNA 合成市场规模及趋势分析（依最终用途），2021 年至 2033 年
  • 生物製药和诊断药物公司
  • 学术研究机构
  • 受託研究机构

第七章 竞争态势

  • 公司/竞争对手分类
  • 战略地图
  • 2024年企业市场分析
  • 公司简介/上市公司
    • Thermo Fisher Scientific Inc.
    • Twist Bioscience
    • BIONEER CORPORATION
    • Eton Bioscience, Inc
    • LGC Biosearch Technologies
    • IBA Lifesciences GmbH
    • Eurofins Scientific
    • Integrated DNA Technologies, Inc.
    • Quintara Biosciences
    • GenScript
Product Code: GVR-4-68040-689-4

U.S. DNA Synthesis Market Summary

The U.S. DNA synthesis market size was estimated at USD 1.25 billion in 2024 and is projected to reach USD 4.62 billion by 2033, expanding at a CAGR of 15.93% from 2025 to 2033. This high growth is driven by increasing demand in synthetic biology, personalized medicine, and biotechnology research. Advancements in gene editing technologies and declining costs of U.S. DNA synthesis are further accelerating market expansion. The U.S. remains a key player in global genomic innovation, supported by strong investment in R&D and a well-established biotech infrastructure.

U.S. DNA Synthesis Market Report Segmentation

This report forecasts revenue growth and provides an analysis on the latest trends in each of the sub-segments from 2021 to 2033. For the purpose of this report, Grand View Research has segmented the U.S. DNA synthesis market on the basis of service type, application, and end use.

  • Service Type Outlook (Revenue, USD Million, 2021 - 2033)
  • Oligonucleotide Synthesis
    • By Type
    • Standard Oligonucleotide Synthesis
    • Custom Oligonucleotide Synthesis
    • By Length
    • Less than 50 nt
    • 51-100 nt
    • 101-150 nt
    • More than 150 nt
  • Gene Synthesis
    • By Type
    • Custom Gene Synthesis
    • Gene Library Synthesis
    • By Length
    • Less than 500 nt
    • 501-1000 nt
    • 1001-1500 nt
    • 1501-2000 nt
    • 2001-2500 nt
    • More than 2500 nt
  • Application Outlook (Revenue, USD Million, 2021 - 2033)
  • Research and Development
    • Oligonucleotide Synthesis
    • PCR
    • NGS
    • CRISPR
    • Cloning and Mutagenesis
    • Others
    • Gene Synthesis
    • Synthetic Biology
    • Vaccine Development
    • Genetic Engineering
    • Others
  • Diagnostics
  • Therapeutics
    • RNAi Therapies
    • Antisense Oligonucleotide-based Therapies
    • Others
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • Biopharmaceutical and Diagnostics Companies
  • Academic and Research Institutes
  • Contract Research Organizations

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Service Type
    • 1.2.2. Application
    • 1.2.3. End Use
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Insights Landscape

Chapter 3. U.S. DNA Synthesis Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook.
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
    • 3.2.2. Market restraint analysis
  • 3.3. U.S. DNA synthesis Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
    • 3.3.2. PESTEL Analysis

Chapter 4. U.S. DNA Synthesis Market: Service Type Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. U.S. DNA Synthesis Market Service Type Movement Analysis
  • 4.3. U.S. DNA Synthesis Market Size & Trend Analysis, by Service Type, 2021 to 2033 (USD Million)
  • 4.4. Oligonucleotide synthesis
    • 4.4.1. Oligonucleotides synthesis market estimates and forecasts 2021 to 2033 (USD Million)
    • 4.4.2. By Type
      • 4.4.2.1. Standard oligonucleotides synthesis
        • 4.4.2.1.1. Standard oligonucleotides synthesis market estimates and forecasts 2021 to 2033 (USD Million)
      • 4.4.2.2. Custom oligonucleotide synthesis
        • 4.4.2.2.1. Custom oligonucleotides synthesis market estimates and forecasts 2021 to 2033 (USD Million)
    • 4.4.3. By Length
      • 4.4.3.1. Less than 50nt
        • 4.4.3.1.1. Less than 50nt market estimates and forecasts 2021 to 2033 (USD Million)
      • 4.4.3.2. 51-100nt
        • 4.4.3.2.1. 51-100nt market estimates and forecasts 2021 to 2033 (USD Million)
      • 4.4.3.3. 101-150nt
        • 4.4.3.3.1. 101-150nt synthesis market estimates and forecasts 2021 to 2033 (USD Million)
      • 4.4.3.4. More than 150nt
        • 4.4.3.4.1. More than 150nt synthesis market estimates and forecasts 2021 to 2033 (USD Million)
  • 4.5. Gene synthesis
    • 4.5.1. Gene synthesis market estimates and forecasts 2021 to 2033 (USD Million)
    • 4.5.2. By Type
      • 4.5.2.1. Custom gene synthesis
        • 4.5.2.1.1. Custom gene synthesis market estimates and forecasts 2021 to 2033 (USD Million)
      • 4.5.2.2. Gene library synthesis
        • 4.5.2.2.1. Gene library synthesis market estimates and forecasts 2021 to 2033 (USD Million)
    • 4.5.3. By Length
      • 4.5.3.1. Less than 500nt
        • 4.5.3.1.1. Less than 500nt market estimates and forecasts 2021 to 2033 (USD Million)
      • 4.5.3.2. 501-1000nt
        • 4.5.3.2.1. 501-1000nt market estimates and forecasts 2021 to 2033 (USD Million)
      • 4.5.3.3. 1001-1500nt
        • 4.5.3.3.1. 1001-1500nt synthesis market estimates and forecasts 2021 to 2033 (USD Million)
      • 4.5.3.4. 1501-2000nt
        • 4.5.3.4.1. 1501-2000nt synthesis market estimates and forecasts 2021 to 2033 (USD Million)
      • 4.5.3.5. 2001-2500nt
        • 4.5.3.5.1. 2001-2500nt synthesis market estimates and forecasts 2021 to 2033 (USD Million)
      • 4.5.3.6. More than 2500nt
        • 4.5.3.6.1. More than 2500nt synthesis market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 5. U.S. DNA Synthesis Market: Application Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. U.S. DNA Synthesis Market Application Movement Analysis
  • 5.3. U.S. DNA Synthesis Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
  • 5.4. Research & Development
    • 5.4.1. Research & development market estimates and forecasts 2021 to 2033 (USD Million)
    • 5.4.2. Oligonucleotide synthesis
      • 5.4.2.1. Oligonucleotide synthesis tumors market estimates and forecasts 2021 to 2033 (USD Million)
      • 5.4.2.2. PCR
        • 5.4.2.2.1. PCR synthesis tumors market estimates and forecasts 2021 to 2033 (USD Million)
      • 5.4.2.3. NGS
        • 5.4.2.3.1. NGS synthesis tumors market estimates and forecasts 2021 to 2033 (USD Million)
      • 5.4.2.4. CRISPR
        • 5.4.2.4.1. CRISPR synthesis tumors market estimates and forecasts 2021 to 2033 (USD Million)
      • 5.4.2.5. Cloning and mutagenesis
        • 5.4.2.5.1. Cloning and mutagenesis synthesis tumors market estimates and forecasts 2021 to 2033 (USD Million)
      • 5.4.2.6. Others
        • 5.4.2.6.1. Others synthesis tumors market estimates and forecasts 2021 to 2033 (USD Million)
    • 5.4.3. Gene synthesis
      • 5.4.3.1. Gene synthesis market estimates and forecasts 2021 to 2033 (USD Million)
      • 5.4.3.2. Synthetic biology
        • 5.4.3.2.1. Synthetic biology tumors market estimates and forecasts 2021 to 2033 (USD Million)
      • 5.4.3.3. Vaccine development
        • 5.4.3.3.1. Vaccine development synthesis tumors market estimates and forecasts 2021 to 2033 (USD Million)
      • 5.4.3.4. Genetic engineering
        • 5.4.3.4.1. Genetic engineering synthesis tumors market estimates and forecasts 2021 to 2033 (USD Million)
      • 5.4.3.5. Others
        • 5.4.3.5.1. Others synthesis tumors market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.5. Diagnostics
    • 5.5.1. Diagnostics market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.6. Therapeutics
    • 5.6.1. Therapeutics market estimates and forecasts 2021 to 2033 (USD Million)
    • 5.6.2. RNAi therapies
      • 5.6.2.1. RNAi therapies market estimates and forecasts 2021 to 2033 (USD Million)
    • 5.6.3. Antisense and oligonucleotide-based therapies
      • 5.6.3.1. Antisense and oligonucleotide-based therapies market estimates and forecasts 2021 to 2033 (USD Million)
    • 5.6.4. Others
      • 5.6.4.1. Others market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 6. U.S. DNA Synthesis Market: End Use Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. U.S. DNA Synthesis Market End Use Movement Analysis
  • 6.3. U.S. DNA Synthesis Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
  • 6.4. Biopharmaceutical & Diagnostic Companies
    • 6.4.1. Biopharmaceutical & diagnostic companies market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.5. Academic & Research Institutes
    • 6.5.1. Academic & research institutes market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.6. Contract Research Organizations
    • 6.6.1. Contract Research Organizations market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Company/Competition Categorization
  • 7.2. Strategy Mapping
  • 7.3. Company Market Position Analysis, 2024
  • 7.4. Company Profiles/Listing
    • 7.4.1. Thermo Fisher Scientific Inc.
      • 7.4.1.1. Company overview
      • 7.4.1.2. Financial performance
      • 7.4.1.3. Service benchmarking
      • 7.4.1.4. Strategic initiatives
    • 7.4.2. Twist Bioscience
      • 7.4.2.1. Company overview
      • 7.4.2.2. Financial performance
      • 7.4.2.3. Service benchmarking
      • 7.4.2.4. Strategic initiatives
    • 7.4.3. BIONEER CORPORATION
      • 7.4.3.1. Company overview
      • 7.4.3.2. Financial performance
      • 7.4.3.3. Service benchmarking
      • 7.4.3.4. Strategic initiatives
    • 7.4.4. Eton Bioscience, Inc
      • 7.4.4.1. Company overview
      • 7.4.4.2. Financial performance
      • 7.4.4.3. Service benchmarking
      • 7.4.4.4. Strategic initiatives
    • 7.4.5. LGC Biosearch Technologies
      • 7.4.5.1. Company overview
      • 7.4.5.2. Financial performance
      • 7.4.5.3. Service benchmarking
      • 7.4.5.4. Strategic initiatives
    • 7.4.6. IBA Lifesciences GmbH
      • 7.4.6.1. Company overview
      • 7.4.6.2. Financial performance
      • 7.4.6.3. Service benchmarking
      • 7.4.6.4. Strategic initiatives
    • 7.4.7. Eurofins Scientific
      • 7.4.7.1. Company overview
      • 7.4.7.2. Financial performance
      • 7.4.7.3. Service benchmarking
      • 7.4.7.4. Strategic initiatives
    • 7.4.8. Integrated DNA Technologies, Inc.
      • 7.4.8.1. Company overview
      • 7.4.8.2. Financial performance
      • 7.4.8.3. Service benchmarking
      • 7.4.8.4. Strategic initiatives
    • 7.4.9. Quintara Biosciences
      • 7.4.9.1. Company overview
      • 7.4.9.2. Financial performance
      • 7.4.9.3. Service benchmarking
      • 7.4.9.4. Strategic initiatives
    • 7.4.10. GenScript
      • 7.4.10.1. Company overview
      • 7.4.10.2. Financial performance
      • 7.4.10.3. Service benchmarking
      • 7.4.10.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviation
  • Table 2 U.S. DNA synthesis market, by service type, 2021 - 2033 (USD Million)
  • Table 3 U.S. DNA synthesis market, by application, 2021 - 2033 (USD Million)
  • Table 4 U.S. DNA synthesis market, by end use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 U.S. DNA synthesis market segmentation
  • Fig. 2 Data analysis models
  • Fig. 3 Market formulation and validation
  • Fig. 4 Data validating & publishing
  • Fig. 5 Market research process
  • Fig. 6 Information procurement
  • Fig. 7 Primary research
  • Fig. 8 Value-chain-based sizing & forecasting
  • Fig. 9 QFD modelling for market share assessment
  • Fig. 10 Market formulation & validation
  • Fig. 11 Commodity flow analysis
  • Fig. 12 Market outlook
  • Fig. 13 Segments snapshot
  • Fig. 14 Competitive landscape snapshot
  • Fig. 15 U.S. DNA synthesis market value, 2024 (USD billion)
  • Fig. 16 Market trends & outlook
  • Fig. 17 PESTEL analysis
  • Fig. 18 Porter's five forces analysis
  • Fig. 19 U.S. DNA synthesis market: Service type outlook & key takeaways
  • Fig. 20 U.S. DNA synthesis market: Service type movement analysis
  • Fig. 21 Oligonucleotide synthesis market estimates and forecasts, 2021 - 2033 (USD million)
  • Fig. 22 Standard oligonucleotide synthesis market estimates and forecasts, 2021 - 2033 (USD million)
  • Fig. 23 Custom oligonucleotide synthesis market estimates and forecasts, 2021 - 2033 (USD million)
  • Fig. 24 Less than 50 nt market estimates and forecasts, 2021 - 2033 (USD million)
  • Fig. 25 51-100 nt market estimates and forecasts, 2021 - 2033 (USD million)
  • Fig. 26 101-150 nt market estimates and forecasts, 2021 - 2033 (USD million)
  • Fig. 27 More than 150 nt market estimates and forecasts, 2021 - 2033 (USD million)
  • Fig. 28 Gene synthesis market estimates and forecasts, 2021 - 2033 (USD million)
  • Fig. 29 Custom gene synthesis market estimates and forecasts, 2021 - 2033 (USD million)
  • Fig. 30 Gene library synthesis market estimates and forecasts, 2021 - 2033 (USD million)
  • Fig. 31 Less than 500 nt market estimates and forecasts, 2021 - 2033 (USD million)
  • Fig. 32 501-1,000 nt market estimates and forecasts, 2021 - 2033 (USD million)
  • Fig. 33 501-1,000 nt market estimates and forecasts, 2021 - 2033 (USD million)
  • Fig. 34 1,501-2,000 nt market estimates and forecasts, 2021 - 2033 (USD million)
  • Fig. 35 2,001-2,500 nt market estimates and forecasts, 2021 - 2033 (USD million)
  • Fig. 36 More than 2,500 nt market estimates and forecasts, 2021 - 2033 (USD million)
  • Fig. 37 U.S. DNA synthesis Market: Application outlook & key takeaways
  • Fig. 38 U.S. DNA synthesis Market: Application movement analysis
  • Fig. 39 Research and development market estimates and forecasts, 2021 - 2033 (USD million)
  • Fig. 40 Oligonucleotide synthesis market estimates and forecasts, 2021 - 2033 (USD million)
  • Fig. 41 PCR market estimates and forecasts, 2021 - 2033 (USD million)
  • Fig. 42 NGS market estimates and forecasts, 2021 - 2033 (USD million)
  • Fig. 43 CRISPR market estimates and forecasts, 2021 - 2033 (USD million)
  • Fig. 44 Cloning and mutagenesis market estimates and forecasts, 2021 - 2033 (USD million)
  • Fig. 45 Others market estimates and forecasts, 2021 - 2033 (USD million)
  • Fig. 46 Gene synthesis market estimates and forecasts, 2021 - 2033 (USD million)
  • Fig. 47 Synthetic biology market estimates and forecasts, 2021 - 2033 (USD million)
  • Fig. 48 Vaccine development market estimates and forecasts, 2021 - 2033 (USD million)
  • Fig. 49 Genetic engineering market estimates and forecasts, 2021 - 2033 (USD million)
  • Fig. 50 Others market estimates and forecasts, 2021 - 2033 (USD million)
  • Fig. 51 Diagnostics market estimates and forecasts, 2021 - 2033 (USD million)
  • Fig. 52 Therapeutics market estimates and forecasts, 2021 - 2033 (USD million)
  • Fig. 53 RNAi therapies market estimates and forecasts, 2021 - 2033 (USD million)
  • Fig. 54 Antisense oligonucleotide-based therapies market estimates and forecasts, 2021 - 2033 (USD million)
  • Fig. 55 Others market estimates and forecasts, 2021 - 2033 (USD million)
  • Fig. 56 U.S. DNA synthesis market: End Use outlook & key takeaways
  • Fig. 57 U.S. DNA synthesis market: End Use movement analysis
  • Fig. 58 Biopharmaceutical and diagnostics companies market estimates and forecasts, 2021 - 2033 (USD million)
  • Fig. 59 Academic & research institutes market estimates and forecasts, 2021 - 2033 (USD million)
  • Fig. 60 Contract research organizations market estimates and forecasts, 2021 - 2033 (USD million)
  • Fig. 61 Strategic framework